58 related articles for article (PubMed ID: 38443680)
21. tRNA
Panoutsopoulou K; Dreyer T; Dorn J; Obermayr E; Mahner S; Gorp TV; Braicu I; Zeillinger R; Magdolen V; Avgeris M; Scorilas A
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008188
[TBL] [Abstract][Full Text] [Related]
22. Research progress on the tsRNA classification, function, and application in gynecological malignant tumors.
Wen JT; Huang ZH; Li QH; Chen X; Qin HL; Zhao Y
Cell Death Discov; 2021 Dec; 7(1):388. PubMed ID: 34907180
[TBL] [Abstract][Full Text] [Related]
23. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.
Qian X; Yang J; Qiu Q; Li X; Jiang C; Li J; Dong L; Ying K; Lu B; Chen E; Liu P; Lu Y
J Hematol Oncol; 2021 Jul; 14(1):112. PubMed ID: 34274028
[TBL] [Abstract][Full Text] [Related]
24. A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer.
Jin F; Yang L; Wang W; Yuan N; Zhan S; Yang P; Chen X; Ma T; Wang Y
Mol Cancer; 2021 Jul; 20(1):95. PubMed ID: 34273975
[No Abstract] [Full Text] [Related]
25. A 5'-tRNA halve, tiRNA-Gly promotes cell proliferation and migration via binding to RBM17 and inducing alternative splicing in papillary thyroid cancer.
Han L; Lai H; Yang Y; Hu J; Li Z; Ma B; Xu W; Liu W; Wei W; Li D; Wang Y; Zhai Q; Ji Q; Liao T
J Exp Clin Cancer Res; 2021 Jul; 40(1):222. PubMed ID: 34225773
[TBL] [Abstract][Full Text] [Related]
26. The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC.
Wang X; Xing L; Yang R; Chen H; Wang M; Jiang R; Zhang L; Chen J
Mol Cancer; 2021 Jun; 20(1):91. PubMed ID: 34116677
[TBL] [Abstract][Full Text] [Related]
27. Origins and evolving functionalities of tRNA-derived small RNAs.
Chen Q; Zhang X; Shi J; Yan M; Zhou T
Trends Biochem Sci; 2021 Oct; 46(10):790-804. PubMed ID: 34053843
[TBL] [Abstract][Full Text] [Related]
28. FUBP1 mediates the growth and metastasis through TGFβ/Smad signaling in pancreatic adenocarcinoma.
Zhang Y; Chen J; Zhou N; Lu Y; Lu J; Xing X; Chen H; Zhang X
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649780
[TBL] [Abstract][Full Text] [Related]
29. A specific tRNA half, 5'tiRNA-His-GTG, responds to hypoxia via the HIF1α/ANG axis and promotes colorectal cancer progression by regulating LATS2.
Tao EW; Wang HL; Cheng WY; Liu QQ; Chen YX; Gao QY
J Exp Clin Cancer Res; 2021 Feb; 40(1):67. PubMed ID: 33588913
[TBL] [Abstract][Full Text] [Related]
30. 5'-tRF-GlyGCC: a tRNA-derived small RNA as a novel biomarker for colorectal cancer diagnosis.
Wu Y; Yang X; Jiang G; Zhang H; Ge L; Chen F; Li J; Liu H; Wang H
Genome Med; 2021 Feb; 13(1):20. PubMed ID: 33563322
[TBL] [Abstract][Full Text] [Related]
31. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
32. tRNA-derived RNA fragments in cancer: current status and future perspectives.
Yu M; Lu B; Zhang J; Ding J; Liu P; Lu Y
J Hematol Oncol; 2020 Sep; 13(1):121. PubMed ID: 32887641
[TBL] [Abstract][Full Text] [Related]
33. Cancer statistics, 2020.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2020 Jan; 70(1):7-30. PubMed ID: 31912902
[TBL] [Abstract][Full Text] [Related]
34. tiRNAs: A novel class of small noncoding RNAs that helps cells respond to stressors and plays roles in cancer progression.
Tao EW; Cheng WY; Li WL; Yu J; Gao QY
J Cell Physiol; 2020 Feb; 235(2):683-690. PubMed ID: 31286522
[TBL] [Abstract][Full Text] [Related]
35. A tRNA fragment, 5'-tiRNA
Mo D; Jiang P; Yang Y; Mao X; Tan X; Tang X; Wei D; Li B; Wang X; Tang L; Yan F
Cancer Lett; 2019 Aug; 457():60-73. PubMed ID: 31078732
[TBL] [Abstract][Full Text] [Related]
36. Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis.
Zhu L; Li J; Gong Y; Wu Q; Tan S; Sun D; Xu X; Zuo Y; Zhao Y; Wei YQ; Wei XW; Peng Y
Mol Cancer; 2019 Apr; 18(1):74. PubMed ID: 30940133
[TBL] [Abstract][Full Text] [Related]
37. RNA therapy: Are we using the right molecules?
Yu AM; Jian C; Yu AH; Tu MJ
Pharmacol Ther; 2019 Apr; 196():91-104. PubMed ID: 30521885
[TBL] [Abstract][Full Text] [Related]
38. The master regulator FUBP1: its emerging role in normal cell function and malignant development.
Debaize L; Troadec MB
Cell Mol Life Sci; 2019 Jan; 76(2):259-281. PubMed ID: 30343319
[TBL] [Abstract][Full Text] [Related]
39. tsRNAs: The Swiss Army Knife for Translational Regulation.
Shi J; Zhang Y; Zhou T; Chen Q
Trends Biochem Sci; 2019 Mar; 44(3):185-189. PubMed ID: 30297206
[TBL] [Abstract][Full Text] [Related]
40. Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells.
Guzzi N; Cieśla M; Ngoc PCT; Lang S; Arora S; Dimitriou M; Pimková K; Sommarin MNE; Munita R; Lubas M; Lim Y; Okuyama K; Soneji S; Karlsson G; Hansson J; Jönsson G; Lund AH; Sigvardsson M; Hellström-Lindberg E; Hsieh AC; Bellodi C
Cell; 2018 May; 173(5):1204-1216.e26. PubMed ID: 29628141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
